- Report
- March 2024
- 180 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 139 Pages
Global
From €2895EUR$2,999USD£2,483GBP
- Report
- February 2019
- 156 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- June 2018
- 103 Pages
Global
From €10612EUR$10,995USD£9,103GBP
- Report
- April 2018
Global
From €965EUR$1,000USD£828GBP
- Report
- February 2024
- 181 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- March 2022
- 270 Pages
Global
From €5953EUR$6,168USD£5,107GBP
Provigil is a prescription medication used to treat excessive sleepiness caused by certain medical conditions, such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is a central nervous system (CNS) stimulant drug, classified as a Schedule IV controlled substance by the U.S. Drug Enforcement Administration. Provigil is approved by the U.S. Food and Drug Administration (FDA) for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder.
Provigil is part of the larger CNS drug market, which includes drugs used to treat a variety of neurological and psychiatric conditions. These drugs are used to treat conditions such as depression, anxiety, insomnia, and attention deficit hyperactivity disorder (ADHD).
Some of the companies in the Provigil market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more